AzTrials
AzTrials

Pacemaker DependenceNCT04952649

The Ability of Peripheral Perfusion Index To Detect Changes of Hemodynamics in Patients With Pacemaker

An observational study of Pacemaker Dependence, run by Shanghai Zhongshan Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Pacemakers are widely used in postcardiotomy patients to avoid severe arrhythmia. The peripheral perfusion index (PI) has been considered as an effective parameter evaluating the circulation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pacemaker Dependence
How many people
50 participants
Where
1 siteChina
Study dates
7 Jul 2021to 30 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Pacemakers are widely used in post-cardiotomy patients, while it's common that some patients may be pacemaker dependent. We choose these patients who has been placed with temportary pacemaker during the cardic surgery

Who may be able to join

  • age >=18 years old;
  • postcardiotomy
  • placement of temportary pacemaker during the surgery
  • dependence of pacemaker (abscence of autonomic cardiac rhythm)

Who cannot join

  • hemodynamic unstable (high dose of vasoactive drugs)
  • fingers ischemia, cannot monitor the peripheral perfusion index

Trial locations and contacts

1 site in 1 country.

Guo-wei Tu, MD PhD contact

13501996995

tu.guowei@zs-hospital.sh.cn

China1 site, 1 recruiting
  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, 200032

    Guo-wei Tu, Doctor, 86-13501996995, tu.guowei@zs-hospital.sh.cn

    Recruiting

Other trials in China

About this study

Official title: The Ability of Peripheral Perfusion Index To Detect Changes of Hemodynamics in Patients With Pacemaker:a Prospective Study

Pacemakers are widely used in postcardiotomy patients to avoid severe arrhythmia. The peripheral perfusion index (PI) has been considered as an effective parameter evaluating the circulation. In this study, investigators aim to avaluate the ability of peripheral perfusion index to detect changes of hemodynamics in postcardiotomy patients with pacemakers.

Read the detailed description

Pacemakers are widely used in postcardiotomy patients to avoid severe arrhythmia. The peripheral perfusion index (PI) has been considered as an effective parameter evaluating the circulation. In this study, investigators aim to evaluate the ability of peripheral perfusion index to detect changes of hemodynamics (cardiac output or storke volume,et al) in postcardiotomy patients with pacemakers.

Keywords
peripheral perfusion index, cardiac output, stroke volume

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04952649
Study groupRoleWhat they receive
pacemaker dependent patients after cardiac surgeryPacemakers are widely used in cardiotomy patients, while it's common that the patients happen to be pacemaker dependent. When the doctor decides to set the heart rate of the pacemaker, we record the hemodynamic parameters and peripheral perfusion index from 70-80-90-100-110 bpm.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiac output

    Measurement of cardiac output by Flotrac ,the metric is L/min.

    Measured: During the study procedure

  2. stroke volume

    Measurement of stroke volume by Flotrac ,the metric is ml.

    Measured: During the study procedure

  3. Peripheral perfusion index

    Measurement of Peripheral perfusion index by masimo radical.

    Measured: During the study procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2021
  2. Study start7 Jul 2021
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04952649
Sponsor's protocol ID
PITCH
Status last verified
Jul 2021
First submitted
18 Jun 2021
Last updated
15 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bazaraa H, Roby S, Salah E, Algebaly H. Assessment of Tissue Perfusion Using the Peripheral Perfusion Index and Lactate Clearance in Shock in Pediatric Patients. Shock. 2021 Dec 1;56(6):933-938. doi: 10.1097/SHK.0000000000001811.

    PubMed 34014888
  • Abdel-Ghaffar HS, Abdel-Wahab AH, Roushdy MM. Using the Perfusion Index to predict changes in the depth of anesthesia in children compared with the A-line Autoregression Index: an observational study. Braz J Anesthesiol. 2024 Sep-Oct;74(5):744169. doi: 10.1016/j.bjane.2021.04.030. Epub 2021 May 12.

    PubMed 33991553

Questions about this trial

What is this clinical trial studying?

An observational study of Pacemaker Dependence, run by Shanghai Zhongshan Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Guo-wei Tu, MD PhD (13501996995, tu.guowei@zs-hospital.sh.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiac output (time frame: During the study procedure). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04952649, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in